-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We keep our target at $410, on a P/E of 17.7x our 2027 EPS view vs the peer average of 12.4x. We increase our 2026 EPS estimate by $0.93 to $19.38 and 2027's by $1.40 to $23.10. Q1 2026 was a strong quarter for EVR, with broad-based record results across North American Advisory, EMEA Advisory, PCA, PFG, Equities, and Wealth Management. The firm continued to gain market share, ranking #5 in global announced M&A (vs. #12 Y/Y per LSEG Data & Analytics), supported by record backlogs that are replenishing at healthy rates across all businesses. However, management acknowledged that Q1 benefited from exceptional deal timing, as certain Q4 2025 deals slipped into Q1 and expected Q2 2026 transactions accelerated into the quarter. Accordingly, management guided investors to expect Q2 2026 revenues closer to Q2 2025 levels, tempering expectations for sequential growth. Despite near-term lumpiness, we think the underlying momentum remains strong, with a robust pipeline positioning EVR well for continued growth in 2026.